ACSL1 Antikörper (AA 48-145)
-
- Target Alle ACSL1 (Acsl1) Antikörper anzeigen
- ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
-
Bindungsspezifität
- AA 48-145
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser ACSL1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant ACSL1.
- Sequenz
- PKPLKPPCDL SMQSVEVAGS GGARRSALLD SDEPLVYFYD DVTTLYEGFQ RGIQVSNNGP CLGSRKPDQP YEWLSYKQVA ELSECIGSAL IQKGFKTA
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- ACSL1 (NP_001986, 48 a.a. ~ 145 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 3G4
- Isotyp
- IgG2a
- Top Product
- Discover our top product Acsl1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study." in: Journal of proteomics, Vol. 113, pp. 57-72, (2014) (PubMed).
: "Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking." in: Archives of biochemistry and biophysics, Vol. 477, Issue 2, pp. 363-71, (2008) (PubMed).
: "
-
Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study." in: Journal of proteomics, Vol. 113, pp. 57-72, (2014) (PubMed).
-
- Target
- ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
- Andere Bezeichnung
- ACSL1 (Acsl1 Produkte)
- Synonyme
- ACS1 antikoerper, FACL1 antikoerper, FACL2 antikoerper, LACS antikoerper, LACS1 antikoerper, LACS2 antikoerper, Acas antikoerper, Acas1 antikoerper, Acs antikoerper, FACS antikoerper, Facl2 antikoerper, ACS antikoerper, COAA antikoerper, zgc:110081 antikoerper, CER8 antikoerper, ECERIFERUM 8 antikoerper, LONG-CHAIN ACYL-COA SYNTHASE 1 antikoerper, T8I13.8 antikoerper, F13F21.14 antikoerper, F13F21_14 antikoerper, LATERAL ROOT DEVELOPMENT 2 antikoerper, LRD2 antikoerper, long-chain acyl-CoA synthetase 2 antikoerper, acyl-CoA synthetase long chain family member 1 antikoerper, acyl-CoA synthetase long-chain family member 1 antikoerper, acyl-CoA synthetase long chain family member 1a antikoerper, AMP-dependent synthetase and ligase family protein antikoerper, long-chain acyl-CoA synthetase 2 antikoerper, ACSL1 antikoerper, Acsl1 antikoerper, acsl1a antikoerper, LACS1 antikoerper, LACS2 antikoerper
- Hintergrund
-
Full Gene Name: acyl-CoA synthetase long-chain family member 1
Synonyms: ACS1,FACL1,FACL2,LACS,LACS1,LACS2 - Gen-ID
- 2180
- NCBI Accession
- NM_001995
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-